Literature DB >> 15112064

Rapid detection of Mycoplasma pneumoniae IgM antibodies in pediatric patients using ImmunoCard Mycoplasma compared to conventional enzyme immunoassays.

J J Dunn1, A K Malan, J Evans, C M Litwin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112064     DOI: 10.1007/s10096-004-1120-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia.

Authors:  T Watkins-Riedel; G Stanek; F Daxboeck
Journal:  Diagn Microbiol Infect Dis       Date:  2001 May-Jun       Impact factor: 2.803

Review 2.  Infections due to species of Mycoplasma and Ureaplasma: an update.

Authors:  D Taylor-Robinson
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

3.  Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial.

Authors:  T S Alexander; L D Gray; J A Kraft; D S Leland; M T Nikaido; D H Willis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.

Authors:  N Principi; S Esposito; F Blasi; L Allegra
Journal:  Clin Infect Dis       Date:  2001-04-10       Impact factor: 9.079

5.  Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum.

Authors:  W L Thacker; D F Talkington
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 6.  Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures.

Authors:  A Ferwerda; H A Moll; R de Groot
Journal:  Eur J Pediatr       Date:  2001-08       Impact factor: 3.183

Review 7.  Laboratory diagnosis of Mycoplasma pneumoniae infection.

Authors:  F Daxboeck; R Krause; C Wenisch
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

8.  Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections.

Authors:  J Petitjean; A Vabret; S Gouarin; F Freymuth
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Evaluation of Meridian ImmunoCard Mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in paediatric patients.

Authors:  L Matas; J Domínguez; F De Ory; N García; N Galí; P J Cardona; A Hernández; C Rodrigo; V Ausina
Journal:  Scand J Infect Dis       Date:  1998

10.  Diagnosis of Mycoplasma pneumoniae pneumonia in children.

Authors:  M E Waris; P Toikka; T Saarinen; S Nikkari; O Meurman; R Vainionpää; J Mertsola; O Ruuskanen
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  10 in total
  3 in total

1.  Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children.

Authors:  Tsutomu Yamazaki; Mitsuo Narita; Nozomu Sasaki; Tsuyoshi Kenri; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Clin Vaccine Immunol       Date:  2006-06

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.

Authors:  N Miyashita; Y Kawai; T Yamaguchi; K Ouchi; M Oka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.